Compare Howmet Aerospace Inc (HWM) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Howmet Aerospace Inc vs Repligen Corporation Common Stock — how do they compare? Howmet Aerospace Inc trades at $217.54 (market cap $86.48B), while Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B). The key difference: Howmet Aerospace Inc is far larger — about 7.8× Repligen Corporation Common Stock's market cap, and Howmet Aerospace Inc pays a 0.26% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Howmet Aerospace Inc for 35 Days and Repligen Corporation Common Stock for 0 Days on average.
| HWM | RGEN | |
|---|---|---|
Market Cap | $86.48B | $11.14B |
Volume | 3,558,498 | 1,259,263 |
Sector | Industrials | Health |
52-Week High | $292.65 | $194.57 |
52-Week Low | $189.68 | $102.87 |
Typical Hold Time | 35 Days | 0 Days |
Enterprise Value | $90.58B | $11.02B |
Dividend Yield | 0.26% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Howmet Aerospace (HWM) trades at $216.84, down 1.8% with bearish technical signals despite strong fundamentals. The company has consistently beaten earnings estimates in recent quarters with Q2 2026 EPS of $1.33 exceeding expectations. Revenue growth continues with 2026 projections showing $9.1B revenue and 20.52% net margin. Analyst consensus remains strongly bullish with 84% buy ratings and $328.10 price target representing 51% upside potential.
The stock presents compelling growth potential driven by aerospace demand and defense modernization trends, though technical weakness and valuation concerns at 46.7x P/E warrant caution. Strong cash flow generation supports shareholder returns including dividends and buybacks, while supply chain risks and competitive pressures remain key watchpoints for investors.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Howmet Aerospace Inc
Howmet Aerospace provides advanced engineered solutions for the aerospace and transportation industries. It specializes in jet engine components, aerospace fastening systems, and forged aluminum wheels.
Read more on HWM →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
